Difficulty: Medium
Average Score: 68%
Practice
Which of the following is the most suitable antiarrhythmic drug for counteracting ventricular extrasystoles due to digoxin toxicity?
Correct answer
A
Rationale
The most suitable antiarrhythmic drug for counteracting ventricular extrasystoles due to digoxin toxicity is Lidocaine (Option A). Lidocaine is a Class IB antiarrhythmic drug that specifically targets ventricular arrhythmias, making it an appropriate choice for ventricular extrasystoles seen in digoxin toxicity.
Quinidine (Option B) is a Class IA antiarrhythmic drug that is more effective for supraventricular arrhythmias and may exacerbate digoxin toxicity due to its interaction with digoxin levels.
Verapamil (Option C) is a calcium channel blocker that is not typically used for ventricular arrhythmias and would not be the first choice for digoxin toxicity-related ventricular extrasystoles.
Amiodarone (Option D) is a Class III antiarrhythmic drug that is effective for both supraventricular and ventricular arrhythmias but is not the drug of choice for ventricular extrasystoles specifically related to digoxin toxicity.
In an educational context, understanding the mechanisms of action and specific indications of antiarrhythmic drugs is crucial for safe and effective pharmacological management of arrhythmias. This scenario highlights the importance of selecting the most appropriate drug based on the underlying cause of the arrhythmia to optimize patient outcomes and minimize adverse effects.
Quinidine (Option B) is a Class IA antiarrhythmic drug that is more effective for supraventricular arrhythmias and may exacerbate digoxin toxicity due to its interaction with digoxin levels.
Verapamil (Option C) is a calcium channel blocker that is not typically used for ventricular arrhythmias and would not be the first choice for digoxin toxicity-related ventricular extrasystoles.
Amiodarone (Option D) is a Class III antiarrhythmic drug that is effective for both supraventricular and ventricular arrhythmias but is not the drug of choice for ventricular extrasystoles specifically related to digoxin toxicity.
In an educational context, understanding the mechanisms of action and specific indications of antiarrhythmic drugs is crucial for safe and effective pharmacological management of arrhythmias. This scenario highlights the importance of selecting the most appropriate drug based on the underlying cause of the arrhythmia to optimize patient outcomes and minimize adverse effects.